World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
43
Citations
5267
World Ranking
4860
National Ranking
2176

Xue-Feng Bai publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xue-Feng Bai sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 97 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xue-Feng Bai D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xue-Feng Bai sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xue-Feng Bai is affiliated with The Ohio State University in the United States. Their research is primarily concentrated in the fields of Medicine and Immunology and Microbiology, with significant contributions to subfields such as Immunology, Oncology, Molecular Biology, Biomedical Engineering, and Neurology.

The scientist's work addresses a range of topics, notably in cancer and immune-related research. Key topics include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Nanoplatforms for cancer theranostics
  • Neuroinflammation and Neurodegeneration Mechanisms

Among their recent papers are studies published in well-regarded journals covering innovative approaches in cancer treatment and nanomaterials. Notable publications include:

  • Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy, 2022, Journal of Controlled Release
  • Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy, 2020, Nano Today
  • Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy, 2021, Nano Letters
  • Advances in nanomaterials for treatment of hypoxic tumor, 2020, National Science Review
  • CD200 promotes immunosuppression in the pancreatic tumor microenvironment, 2020, Journal for ImmunoTherapy of Cancer

Their collaborative research network includes frequent coauthors such as Jin-Qing Liu, Jianmin Zhu, Fatemeh Talebian, Xian-Zheng Zhang, and William E. Carson.

Xue-Feng Bai has contributed multiple papers to a variety of scientific venues. Some journals with recurrent publications include:

  • The Journal of Immunology
  • Frontiers in Cell and Developmental Biology
  • Frontiers in Immunology
  • Journal of Asian Architecture and Building Engineering
  • J-Institute

Best Publications

  • Ischemic neurons recruit natural killer cells that accelerate brain infarction

    Yan Gan;Yan Gan;Qiang Liu;Qiang Liu;Wei Wu;Jun Xiang Yin

  • Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction

    Guo Yun Chen;Xi Chen;Samantha King;Karen A. Cavassani

  • Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis

    Zhihui Wang;Jin-Qing Liu;Zhenzhen Liu;Rulong Shen

  • Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia.

    Ruolan Liu;Antonio La Cava;Xue Feng Bai;Youngheun Jee

  • S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.

    Mohd W. Nasser;Zahida Qamri;Yadwinder S. Deol;Janani Ravi

  • CD24 is a genetic modifier for risk and progression of multiple sclerosis.

    Qunmin Zhou;Kottil Rammohan;Shili Lin;Nikki Robinson

  • B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo.

    Xingluo Liu;Xue-Feng Bai;Jing Wen;Jian-Xin Gao

  • Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.

    Zhang Gx;Xiao Bg;Bai Xf;van der Meide Ph

  • Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells

    Kang Liu;Juliana Idoyaga;Anna Charalambous;Shin Ichiro Fujii

  • Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes

    Xue-Feng Bai;Jinqing Liu;Ou Li;Pan Zheng

  • Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of mRNA Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and Cytolysin

    J. Zhu;X.F. Bai;E. Mix;H. Link

  • Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses

    Li-Xin Wang;Zhen-Yang Mei;Ji-Hao Zhou;Yu-Shi Yao

  • Genetic Modification of T Cells Redirected toward CS1 Enhances Eradication of Myeloma Cells

    Jianhong Chu;Shun He;Youcai Deng;Youcai Deng;Jianying Zhang

  • Increased Th17 and Regulatory T Cell Responses in EBV-Induced Gene 3-Deficient Mice Lead to Marginally Enhanced Development of Autoimmune Encephalomyelitis

    Jin-Qing Liu;Zhenzhen Liu;Xuejun Zhang;Yun Shi

  • CD24 Controls Expansion and Persistence of Autoreactive T Cells in the Central Nervous System during Experimental Autoimmune Encephalomyelitis

    Xue-Feng Bai;Ou Li;Qunmin Zhou;Huiming Zhang

  • The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis.

    Xue-Feng Bai;Jin-Qing Liu;Xingluo Liu;Yong Guo

  • IL-10 Suppresses Experimental Autoimmune Neuritis and Down-regulates TH1-Type Immune Responses

    Xue Feng Bai;Jie Zhu;Guang Xian Zhang;Georgios Kaponides

  • IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.

    Zhenzhen Liu;Jin Qing Liu;Fatemeh Talebian;Lai Chu Wu

  • IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.

    W.-H. Piao;Y. H. Jee;Y. H. Jee;R. L. Liu;S. W. Coons

  • Perinatal Blockade of B7-1 and B7-2 Inhibits Clonal Deletion of Highly Pathogenic Autoreactive T Cells

    Jian-Xin Gao;Huiming Zhang;Xue-Feng Bai;Jing Wen

Frequent Co-Authors

Hans Link
Hans Link Karolinska Institute
Pan Zheng
Pan Zheng University of Maryland, Baltimore
Fu-Dong Shi
Fu-Dong Shi Tianjin Medical University General Hospital
Bao-Guo Xiao
Bao-Guo Xiao Fudan University
Yang Liu
Yang Liu University of Michigan–Ann Arbor
Jianhua Yu
Jianhua Yu City Of Hope National Medical Center
Timothy Vollmer
Timothy Vollmer University of Florida
Jie Zhu
Jie Zhu Jilin University
William E. Carson
William E. Carson The Ohio State University
Antonio La Cava
Antonio La Cava University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can expand career opportunities in healthcare and research. Nursing, for example, offers pathways that intersect closely with immunological knowledge, especially in advanced practice roles.

Many healthcare professionals consider programs like the how much do dnp nurses make resource to understand the earning potential after obtaining a Doctor of Nursing Practice degree. This degree complements immunology studies by enhancing clinical skills and leadership in patient care.

If you're already a Family Nurse Practitioner (FNP) and want to specialize further, transitioning via the fnp to acnp pathway offers specialized training in acute care. This direction often benefits from a strong background in immunology given the critical care requirements of immune system-related conditions.

Another option includes accelerated programs, such as those found in accelerated rn to np programs, designed for registered nurses to become nurse practitioners more quickly. These programs often incorporate immunology concepts vital for advanced practice roles.

For individuals coming from non-nursing backgrounds, beginning with best online bsn programs for non nurses provides a strong foundation. This degree serves as a critical step toward advanced immunology-related health professions.

Best Scientists Citing Xue-Feng Bai

Trending Scientists

Recently Published Articles